Italy Reimbursement Profile

Posted 14 September 2017 By Patrizia Berto, PharmD, MBA

placeholder+image This profile summarizes the reimbursement process in Italy, presents key stakeholders and highlights what should be considered early in the development process.

Share this article:

Categories: Biologics and biotechnology, Drugs, Medical Devices, Reimbursement, Features, Europe, EMA

Tags: AIFA, Agenzia Italiana del Farmaco, Reimbursement

Regulatory Exchange: Latest Updates From the Community